Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.80
-0.07-0.64%
Last update: Nov 14, 9:30 AM
Comments
Loading...
Cross Country Healthcare Analyst Ratings and Price Targets | NASDAQ:CCRN | Benzinga
Cross Country Healthcare Inc has a consensus price target of $22.59 based on the ratings of 10 analysts. The high is $32 issued by Credit Suisse on February 23, 2023. The low is $16.5 issued by UBS on May 13, 2025. The 3 most-recent analyst ratings were released by Barrington Research, UBS, and Barrington Research on June 17, 2025, May 13, 2025, and March 14, 2025, respectively. With an average price target of $17.91 between Barrington Research, UBS, and Barrington Research, there's an implied 65.80% upside for Cross Country Healthcare Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barrington Research
UBS
Truist Securities
Benchmark
Jefferies
1calculated from analyst ratings
Analyst Ratings for Cross Country Healthcare
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
06/17/2025 | 72.31% | Barrington Research | $18.61 → $18.61 | Maintains | Market Perform | |||
05/13/2025 | 52.78% | UBS | $18.61 → $16.5 | Maintains | Neutral | |||
03/14/2025 | 72.31% | Barrington Research | $18.61 → $18.61 | Maintains | Market Perform | |||
03/06/2025 | 72.31% | UBS | $14 → $18.61 | Maintains | Hold Neutral | |||
02/06/2025 | — | JMP Securities | — | Reiterates | Market Perform → Market Perform | |||
12/10/2024 | — | Barrington Research | — | Downgrade | Outperform → Market Perform | |||
12/05/2024 | 72.31% | Truist Securities | $15 → $18.61 | Maintains | Hold | |||
11/08/2024 | 29.63% | UBS | $19 → $14 | Maintains | Neutral | |||
11/07/2024 | 66.67% | Benchmark | $19 → $18 | Maintains | Buy | |||
10/21/2024 | 38.89% | Truist Securities | $17 → $15 | Maintains | Hold | |||
08/08/2024 | 75.93% | Barrington Research | $21 → $19 | Maintains | Outperform | |||
08/01/2024 | 57.41% | Truist Securities | $16 → $17 | Maintains | Hold | |||
05/06/2024 | 94.44% | Barrington Research | $24 → $21 | Maintains | Outperform | |||
05/02/2024 | 75.93% | Benchmark | $21 → $19 | Maintains | Buy | |||
02/27/2024 | 122.22% | Barrington Research | $26 → $24 | Maintains | Outperform | |||
02/22/2024 | 48.15% | Truist Securities | $22 → $16 | Maintains | Hold | |||
02/22/2024 | 94.44% | Benchmark | $24 → $21 | Maintains | Buy | |||
12/06/2023 | — | JMP Securities | — | Initiates | → Market Perform | |||
11/30/2023 | 103.7% | UBS | → $22 | Initiates | → Neutral | |||
11/29/2023 | 140.74% | Barrington Research | $29 → $26 | Maintains | Outperform | |||
11/03/2023 | 103.7% | Truist Securities | $25 → $22 | Maintains | Hold | |||
11/03/2023 | 94.44% | Jefferies | $32 → $21 | Downgrade | Buy → Hold | |||
10/05/2023 | 196.3% | Jefferies | $40 → $32 | Maintains | Buy | |||
08/14/2023 | 168.52% | Barrington Research | $35 → $29 | Maintains | Outperform | |||
08/08/2023 | 140.74% | Credit Suisse | $27 → $26 | Maintains | Neutral | |||
06/26/2023 | — | William Blair | — | Initiates | → Outperform | |||
06/01/2023 | 224.07% | Barrington Research | $42 → $35 | Maintains | Outperform | |||
05/05/2023 | 150% | Credit Suisse | $32 → $27 | Maintains | Neutral | |||
05/02/2023 | 131.48% | Truist Securities | $38 → $25 | Maintains | Hold | |||
03/10/2023 | 177.78% | Loop Capital | → $30 | Initiates | → Buy | |||
02/23/2023 | 270.37% | Benchmark | $45 → $40 | Maintains | Buy | |||
02/23/2023 | 196.3% | Credit Suisse | $31 → $32 | Maintains | Neutral |
FAQ
What is the target price for Cross Country Healthcare (CCRN) stock?
The latest price target for Cross Country Healthcare (NASDAQ:CCRN) was reported by Barrington Research on June 17, 2025. The analyst firm set a price target for $18.61 expecting CCRN to rise to within 12 months (a possible 72.31% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cross Country Healthcare (CCRN)?
The latest analyst rating for Cross Country Healthcare (NASDAQ:CCRN) was provided by Barrington Research, and Cross Country Healthcare maintained their market perform rating.
When was the last upgrade for Cross Country Healthcare (CCRN)?
There is no last upgrade for Cross Country Healthcare
When was the last downgrade for Cross Country Healthcare (CCRN)?
The last downgrade for Cross Country Healthcare Inc happened on December 10, 2024 when Barrington Research changed their price target from N/A to N/A for Cross Country Healthcare Inc.
When is the next analyst rating going to be posted or updated for Cross Country Healthcare (CCRN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cross Country Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cross Country Healthcare was filed on June 17, 2025 so you should expect the next rating to be made available sometime around June 17, 2026.
Is the Analyst Rating Cross Country Healthcare (CCRN) correct?
While ratings are subjective and will change, the latest Cross Country Healthcare (CCRN) rating was a maintained with a price target of $18.61 to $18.61. The current price Cross Country Healthcare (CCRN) is trading at is $10.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
